RXO
RXO · NYSE
About RXO
- Employees
- 6,906
- Headquarters
- Charlotte, North Carolina
- Listed
- Oct 27, 2022
- Sector
- Industrials
- Industry
- Ground Transportation
- Website
- rxo.com
RXO key statistics
- Market cap
- 4.70B
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 4.34M
- Volume
- 2.72M
- Open price
- $28.48
- High today
- $28.96
- Low today
- $28.18
- 52 Week high
- $29.90
- 52 Week low
- $10.43
RXO (RXO) at a glance
RXO (RXO) last traded at $28.67, with a market cap of 4.70B and a price-to-earnings ratio of 0.00.
Today the stock has traded between $28.18 and $28.96. The current price is 1.7% above the day's low and 1.0% below its high.
Volume so far is 2.72M shares, below the average of 4.34M shares a day.
Over the past year RXO has ranged from $10.43 to $29.90, and now sits 94% of the way up that range.
RXO met or beat analyst EPS estimates in 5 of the last 8 quarters. In Q2 FY26 it reported $0.06 per share against an estimate of $0.0303.
The average analyst price target is $25.85, 9.8% below the current price, from 17 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy29.4%
- Hold64.7%
- Sell5.9%
- Low
- $17.67
- Now
- $28.67
- High
- $36.75
RXO earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 5 of the last 8 quarters, by 43.6% on average.
- Q3 FY24: reported $0.05 per share against an estimate of $0.0437
- Q4 FY24: reported $0.06 per share against an estimate of $0.0586
- Q1 FY25: reported -$0.03 per share against an estimate of -$0.0188
- Q2 FY25: reported $0.04 per share against an estimate of $0.0199
- Q3 FY25: reported $0.01 per share against an estimate of $0.0361
- Q4 FY25: reported -$0.07 per share against an estimate of -$0.039
- Q1 FY26: reported -$0.09 per share against an estimate of -$0.092
- Q2 FY26: reported $0.06 per share against an estimate of $0.0303
RXO news
- Press releasePRNewswire
- Press releaseBusiness Wire
RXO Named Top Company for Women to Work in Trucking
- Press releasePRNewswire
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RXO, Inc. (NYSE: RXO)
- Press releaseBusiness Wire
RXO Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RXO Inc. - RXO
- Press releasePRNewswire
Are RXO, PTC, LFCR, WAFD Obtaining Fair Deals for their Shareholders?
- Press releaseBusiness Wire
RXO Stock Alert: Halper Sadeh LLC is Investigating Whether RXO Inc. is Obtaining a Fair Price for its Shareholders
- Press releasePRNewswire
RXO SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES RXO INC.
Similar companies
Companies in the same industry as RXO
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.